ASPH staining of 142 patients with primary HNSCC tumors, 10 patients with lymph node metastasis, and 3 patients with CIS were evaluated on our TMA (Figure 1). This evidence concerns the gene ASPH and metastatic malignant neoplasm in the lymph nodes.